Tomas Fernandez Gianotti
Overview
Explore the profile of Tomas Fernandez Gianotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
1672
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pirola C, Fernandez Gianotti T, Sookoian S
Aliment Pharmacol Ther
. 2025 Jan;
61(4):614-627.
PMID: 39744897
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading chronic liver disease worldwide, with alarming prevalence reaching epidemic proportions. Aims And Methods: The objective of this study is to...
2.
Pirola C, Salatino A, Fernandez Gianotti T, Castano G, Garaycoechea M, Sookoian S
EBioMedicine
. 2024 Dec;
111():105525.
PMID: 39700897
No abstract available.
3.
Fainstein-Day P, Serra M, Fernandez Gianotti T, Bosco M, Bell S, Vial M
Medicina (B Aires)
. 2024 Jun;
84(3):433-444.
PMID: 38907957
Introduction: Multiple Endocrine Neoplasia type 1 (MEN1) is an autosomal dominant inherited disease with an estimated prevalence of 2-10:100 000. The main locations of tumors are parathyroid glands (HPT), gastroenteropancreatic...
4.
Pirola C, Salatino A, Fernandez Gianotti T, Castano G, Garaycoechea M, Sookoian S
EBioMedicine
. 2024 Feb;
101:104996.
PMID: 38320344
Background: The pathogenesis of MASLD (metabolic dysfunction-associated steatotic liver disease), including its severe clinical forms, involves complex processes at all levels of biological organization. This study examined the potential link...
5.
Pirola C, Flichman D, Dopazo H, Fernandez Gianotti T, San Martino J, Rohr C, et al.
Hepatol Commun
. 2018 Sep;
2(9):1030-1036.
PMID: 30202818
We report on the presence of a rare nonsense mutation (rs149847328, p.Arg227Ter) in the glucokinase regulator () gene in an adult patient with nonalcoholic fatty liver disease (NAFLD), morbid obesity,...
6.
Sookoian S, Rohr C, Salatino A, Dopazo H, Fernandez Gianotti T, Castano G, et al.
Oncotarget
. 2017 Feb;
8(14):22917-22926.
PMID: 28206970
The human transcriptome comprises a myriad of non protein-coding RNA species, including long noncoding RNAs (lncRNAs), which have a remarkable role in transcriptional and epigenetic regulation. We hypothesized that variants...
7.
Sookoian S, Flichman D, Scian R, Rohr C, Dopazo H, Fernandez Gianotti T, et al.
J Pathol
. 2016 Sep;
240(4):437-449.
PMID: 27577682
Non-alcoholic fatty liver disease (NAFLD) is associated with mitochondrial dysfunction, a decreased liver mitochondrial DNA (mtDNA) content, and impaired energy metabolism. To understand the clinical implications of mtDNA diversity in...
8.
Sookoian S, Castano G, Scian R, Fernandez Gianotti T, Dopazo H, Rohr C, et al.
Am J Clin Nutr
. 2016 Jan;
103(2):422-34.
PMID: 26791191
Background: Extensive epidemiologic studies have shown that cardiovascular disease and the metabolic syndrome (MetS) are associated with serum concentrations of liver enzymes; however, fundamental characteristics of this relation are currently...
9.
Pirola C, Scian R, Fernandez Gianotti T, Dopazo H, Rohr C, San Martino J, et al.
Medicine (Baltimore)
. 2015 Sep;
94(36):e1480.
PMID: 26356709
The 5-Hydroxymethylcytosine (5-hmC) is an epigenetic modification whose role in the pathogenesis of metabolic-related complex diseases remains unexplored; 5-hmC appears to be prevalent in the mitochondrial genome. The Ten-Eleven-Translocation (TET)...
10.
Sookoian S, Fernandez Gianotti T, Burgueno A, Pirola C
Biomol Concepts
. 2015 May;
2(6):445-57.
PMID: 25962047
In this study, we review the current knowledge and recent insights on the role of epigenetic factors in the development of human insulin resistance (IR)- and metabolic syndrome (MS)-related phenotypes,...